Condition
Circadian Disruption
Total Trials
3
Recruiting
0
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed2
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07770958Active Not Recruiting
Circadian Disruption And Cardiovascular Risk In Young Adults With Hypertension
NCT07095270Not ApplicableCompletedPrimary
Evaluation of Circadian OS Technology on Melatonin Suppression
NCT02171273Not ApplicableCompleted
Impact of Chronic Circadian Disruption vs. Chronic Sleep Restriction on Metabolism
Showing all 3 trials